Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced nonsmall-cell lung cancer. - Hirsch,F.R.; Varella-Garcia,M.; Bunn,P.A.; Franklin,W.A.; Dziadziuszko,R.; Thatcher,N. (J Clin Oncol, 2006)